Siemens Healthineers Starts Carve-Out of Diagnostics Business as Olyrian Diagnostics
Siemens Healthineers has begun carving out its in vitro diagnostics unit, which will operate as Olyrian Diagnostics and become a standalone company by mid-2028.
Siemens Healthineers has begun carving out its in vitro diagnostics unit, which will operate as Olyrian Diagnostics and become a standalone company by mid-2028.
NovoPath has introduced a next-generation LIS that integrates digital pathology workflows, unifying case tracking, image management, and reporting to streamline operations and reduce laboratory handoffs.
The FDA has authorized Aletta, the first standalone robotic device for automated blood draws in outpatient settings, allowing one phlebotomist to oversee up to three devices to help address workforce shortages.
Researchers have optimized the PROSPR method to isolate extracellular vesicles directly from whole blood, revealing protein and lipid signatures not detected in plasma.
Bio-Rad has launched Vericheck ddPCR kits for quality control in cell and gene therapy manufacturing, offering validated workflows for mycoplasma detection, capsid analysis, and residual DNA quantification.
QIAGEN has launched QIAsymphony Connect, an IVD-compliant platform for automated nucleic acid extraction, supporting up to 96 samples per run and compatible with existing QIAsymphony reagents and consumables.
Using microfluidic shear stress, the system detaches living cells from excised tissue to support pathology workflows and downstream diagnostic testing.
A recent NYU study finds 68.6% of US adults now access lab results via online portals before clinician review, with comprehension varying by digital literacy and patient-centered communication.
Emerging hazards like aerosolized chemicals and laser equipment demand upgraded protection.
Caresfield launched the Resilience-Ready Lab initiative at ADLM 2026, introducing products aimed at improving specimen integrity and supply chain resilience to help labs meet 2026 National Performance Goals.